img

Global and India Pharma Sustained Release Agent Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Pharma Sustained Release Agent Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Pharma Sustained Release Agent Market
This report focuses on global and India Pharma Sustained Release Agent market, also covers the segmentation data of other regions in regional level and county level.
The global Pharma Sustained Release Agent revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Pharma Sustained Release Agent revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Pharma Sustained Release Agent include Teva Pharmaceutical Industries, Mylan N.V., Valeant Pharmaceuticals International, Pfizer, Sun Pharmaceutical Industries, Novartis AG, AstraZeneca, GlaxoSmithKline and Allergan, etc. The global five biggest players hold a share of % in 2024.
Global Pharma Sustained Release Agent Scope and Market Size
Pharma Sustained Release Agent market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Pharma Sustained Release Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Pharma Sustained Release Agent market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Chitosan

Segment by Application


Pharmaceutical
Health Care
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Pharma Sustained Release Agent definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Pharma Sustained Release Agent companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Pharma Sustained Release Agent in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Sustained Release Agent sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Pharma Sustained Release Agent Product Introduction
1.2 Global Pharma Sustained Release Agent Outlook 2018 VS 2024 VS 2034
1.2.1 Global Pharma Sustained Release Agent Sales in US$ Million for the Year 2018-2034
1.2.2 Global Pharma Sustained Release Agent Sales in Volume for the Year 2018-2034
1.3 India Pharma Sustained Release Agent Outlook 2018 VS 2024 VS 2034
1.3.1 India Pharma Sustained Release Agent Sales in US$ Million for the Year 2018-2034
1.3.2 India Pharma Sustained Release Agent Sales in Volume for the Year 2018-2034
1.4 Pharma Sustained Release Agent Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Pharma Sustained Release Agent in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Pharma Sustained Release Agent Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Pharma Sustained Release Agent Market Dynamics
1.5.1 Pharma Sustained Release Agent Industry Trends
1.5.2 Pharma Sustained Release Agent Market Drivers
1.5.3 Pharma Sustained Release Agent Market Challenges
1.5.4 Pharma Sustained Release Agent Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Pharma Sustained Release Agent by Type
2.1 Pharma Sustained Release Agent Market Segment by Type
2.1.1 Gelatin
2.1.2 Polymers
2.1.3 Minerals
2.1.4 Sugars
2.1.5 Chitosan
2.2 Global Pharma Sustained Release Agent Market Size by Type
2.2.1 Global Pharma Sustained Release Agent Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Pharma Sustained Release Agent Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Pharma Sustained Release Agent Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Pharma Sustained Release Agent Market Size by Type
2.3.1 India Pharma Sustained Release Agent Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Pharma Sustained Release Agent Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Pharma Sustained Release Agent Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Pharma Sustained Release Agent by Application
3.1 Pharma Sustained Release Agent Market Segment by Application
3.1.1 Pharmaceutical
3.1.2 Health Care
3.1.3 Others
3.2 Global Pharma Sustained Release Agent Market Size by Application
3.2.1 Global Pharma Sustained Release Agent Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Pharma Sustained Release Agent Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Pharma Sustained Release Agent Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Pharma Sustained Release Agent Market Size by Application
3.3.1 India Pharma Sustained Release Agent Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Pharma Sustained Release Agent Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Pharma Sustained Release Agent Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Pharma Sustained Release Agent Competitor Landscape by Company
4.1 Global Pharma Sustained Release Agent Market Size by Company
4.1.1 Global Key Manufacturers of Pharma Sustained Release Agent, Ranked by Revenue (2024)
4.1.2 Global Pharma Sustained Release Agent Revenue by Manufacturer (2018-2023)
4.1.3 Global Pharma Sustained Release Agent Sales by Manufacturer (2018-2023)
4.1.4 Global Pharma Sustained Release Agent Price by Manufacturer (2018-2023)
4.2 Global Pharma Sustained Release Agent Concentration Ratio (CR)
4.2.1 Pharma Sustained Release Agent Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pharma Sustained Release Agent in 2024
4.2.3 Global Pharma Sustained Release Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Pharma Sustained Release Agent, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Pharma Sustained Release Agent, Product Offered and Application
4.5 Global Key Manufacturers of Pharma Sustained Release Agent, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Pharma Sustained Release Agent Market Size by Company
4.7.1 Key Players of Pharma Sustained Release Agent in India, Ranked by Revenue (2024)
4.7.2 India Pharma Sustained Release Agent Revenue by Players (2018-2023)
4.7.3 India Pharma Sustained Release Agent Sales by Players (2018-2023)
5 Global Pharma Sustained Release Agent Market Size by Region
5.1 Global Pharma Sustained Release Agent Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Pharma Sustained Release Agent Market Size in Volume by Region (2018-2034)
5.2.1 Global Pharma Sustained Release Agent Sales in Volume by Region: 2018-2023
5.2.2 Global Pharma Sustained Release Agent Sales in Volume Forecast by Region (2024-2034)
5.3 Global Pharma Sustained Release Agent Market Size in Value by Region (2018-2034)
5.3.1 Global Pharma Sustained Release Agent Sales in Value by Region: 2018-2023
5.3.2 Global Pharma Sustained Release Agent Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Pharma Sustained Release Agent Market Size YoY Growth 2018-2034
6.2 Americas Pharma Sustained Release Agent Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Pharma Sustained Release Agent Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Pharma Sustained Release Agent Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Pharma Sustained Release Agent Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Pharma Sustained Release Agent Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Pharma Sustained Release Agent Market Size YoY Growth 2018-2034
7.2 EMEA Pharma Sustained Release Agent Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Pharma Sustained Release Agent Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Pharma Sustained Release Agent Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Pharma Sustained Release Agent Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Pharma Sustained Release Agent Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Pharma Sustained Release Agent Market Size YoY Growth 2018-2034
8.2 China Pharma Sustained Release Agent Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Pharma Sustained Release Agent Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Pharma Sustained Release Agent Market Size YoY Growth 2018-2034
9.2 APAC Pharma Sustained Release Agent Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Pharma Sustained Release Agent Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Pharma Sustained Release Agent Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Pharma Sustained Release Agent Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Pharma Sustained Release Agent Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Company Information
10.1.2 Teva Pharmaceutical Industries Description and Business Overview
10.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Teva Pharmaceutical Industries Pharma Sustained Release Agent Products Offered
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 Mylan N.V.
10.2.1 Mylan N.V. Company Information
10.2.2 Mylan N.V. Description and Business Overview
10.2.3 Mylan N.V. Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan N.V. Pharma Sustained Release Agent Products Offered
10.2.5 Mylan N.V. Recent Development
10.3 Valeant Pharmaceuticals International
10.3.1 Valeant Pharmaceuticals International Company Information
10.3.2 Valeant Pharmaceuticals International Description and Business Overview
10.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Agent Products Offered
10.3.5 Valeant Pharmaceuticals International Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Description and Business Overview
10.4.3 Pfizer Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Pharma Sustained Release Agent Products Offered
10.4.5 Pfizer Recent Development
10.5 Sun Pharmaceutical Industries
10.5.1 Sun Pharmaceutical Industries Company Information
10.5.2 Sun Pharmaceutical Industries Description and Business Overview
10.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sun Pharmaceutical Industries Pharma Sustained Release Agent Products Offered
10.5.5 Sun Pharmaceutical Industries Recent Development
10.6 Novartis AG
10.6.1 Novartis AG Company Information
10.6.2 Novartis AG Description and Business Overview
10.6.3 Novartis AG Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis AG Pharma Sustained Release Agent Products Offered
10.6.5 Novartis AG Recent Development
10.7 AstraZeneca
10.7.1 AstraZeneca Company Information
10.7.2 AstraZeneca Description and Business Overview
10.7.3 AstraZeneca Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.7.4 AstraZeneca Pharma Sustained Release Agent Products Offered
10.7.5 AstraZeneca Recent Development
10.8 GlaxoSmithKline
10.8.1 GlaxoSmithKline Company Information
10.8.2 GlaxoSmithKline Description and Business Overview
10.8.3 GlaxoSmithKline Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.8.4 GlaxoSmithKline Pharma Sustained Release Agent Products Offered
10.8.5 GlaxoSmithKline Recent Development
10.9 Allergan
10.9.1 Allergan Company Information
10.9.2 Allergan Description and Business Overview
10.9.3 Allergan Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Allergan Pharma Sustained Release Agent Products Offered
10.9.5 Allergan Recent Development
10.10 Janssen Pharmaceuticals
10.10.1 Janssen Pharmaceuticals Company Information
10.10.2 Janssen Pharmaceuticals Description and Business Overview
10.10.3 Janssen Pharmaceuticals Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Janssen Pharmaceuticals Pharma Sustained Release Agent Products Offered
10.10.5 Janssen Pharmaceuticals Recent Development
10.11 Mayne Pharma Group
10.11.1 Mayne Pharma Group Company Information
10.11.2 Mayne Pharma Group Description and Business Overview
10.11.3 Mayne Pharma Group Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Mayne Pharma Group Pharma Sustained Release Agent Products Offered
10.11.5 Mayne Pharma Group Recent Development
10.12 BASF
10.12.1 BASF Company Information
10.12.2 BASF Description and Business Overview
10.12.3 BASF Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.12.4 BASF Pharma Sustained Release Agent Products Offered
10.12.5 BASF Recent Development
10.13 International Flavors & Fragrances
10.13.1 International Flavors & Fragrances Company Information
10.13.2 International Flavors & Fragrances Description and Business Overview
10.13.3 International Flavors & Fragrances Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.13.4 International Flavors & Fragrances Pharma Sustained Release Agent Products Offered
10.13.5 International Flavors & Fragrances Recent Development
10.14 Ashland Global
10.14.1 Ashland Global Company Information
10.14.2 Ashland Global Description and Business Overview
10.14.3 Ashland Global Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Ashland Global Pharma Sustained Release Agent Products Offered
10.14.5 Ashland Global Recent Development
10.15 Evonik Industries
10.15.1 Evonik Industries Company Information
10.15.2 Evonik Industries Description and Business Overview
10.15.3 Evonik Industries Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Evonik Industries Pharma Sustained Release Agent Products Offered
10.15.5 Evonik Industries Recent Development
10.16 Croda International
10.16.1 Croda International Company Information
10.16.2 Croda International Description and Business Overview
10.16.3 Croda International Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Croda International Pharma Sustained Release Agent Products Offered
10.16.5 Croda International Recent Development
10.17 Gattefosse
10.17.1 Gattefosse Company Information
10.17.2 Gattefosse Description and Business Overview
10.17.3 Gattefosse Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Gattefosse Pharma Sustained Release Agent Products Offered
10.17.5 Gattefosse Recent Development
10.18 Merck KGaA
10.18.1 Merck KGaA Company Information
10.18.2 Merck KGaA Description and Business Overview
10.18.3 Merck KGaA Pharma Sustained Release Agent Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Merck KGaA Pharma Sustained Release Agent Products Offered
10.18.5 Merck KGaA Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Pharma Sustained Release Agent Industry Chain Analysis
11.2 Pharma Sustained Release Agent Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Pharma Sustained Release Agent Production Mode & Process
11.4 Pharma Sustained Release Agent Sales and Marketing
11.4.1 Pharma Sustained Release Agent Sales Channels
11.4.2 Pharma Sustained Release Agent Distributors
11.5 Pharma Sustained Release Agent Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Pharma Sustained Release Agent CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Pharma Sustained Release Agent Market Trends
Table 3. Pharma Sustained Release Agent Market Drivers
Table 4. Pharma Sustained Release Agent Market Challenges
Table 5. Pharma Sustained Release Agent Market Restraints
Table 6. Global Pharma Sustained Release Agent Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Pharma Sustained Release Agent Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Pharma Sustained Release Agent Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Pharma Sustained Release Agent Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Pharma Sustained Release Agent, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Pharma Sustained Release Agent Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Pharma Sustained Release Agent Revenue Share by Manufacturer, 2018-2023
Table 13. Global Pharma Sustained Release Agent Sales by Manufacturer, (Kiloton), 2018-2023
Table 14. Global Pharma Sustained Release Agent Sales Share by Manufacturer, 2018-2023
Table 15. Global Pharma Sustained Release Agent Price by Manufacturer (2018-2023) & (US$/Ton)
Table 16. Global Pharma Sustained Release Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pharma Sustained Release Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sustained Release Agent as of 2024)
Table 18. Global Key Manufacturers of Pharma Sustained Release Agent, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Pharma Sustained Release Agent, Product Offered and Application
Table 20. Global Key Manufacturers of Pharma Sustained Release Agent, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Pharma Sustained Release Agent in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Pharma Sustained Release Agent Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Pharma Sustained Release Agent Revenue Share by Players, (2018-2023)
Table 25. India Pharma Sustained Release Agent Sales by Players, (Kiloton), (2018-2023)
Table 26. India Pharma Sustained Release Agent Sales Share by Players, (2018-2023)
Table 27. Global Pharma Sustained Release Agent Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Pharma Sustained Release Agent Sales in Volume by Region (2018-2023) & (Kiloton)
Table 29. Global Pharma Sustained Release Agent Sales in Volume Forecast by Region (2024-2034) & (Kiloton)
Table 30. Global Pharma Sustained Release Agent Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Pharma Sustained Release Agent Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Pharma Sustained Release Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Pharma Sustained Release Agent Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Pharma Sustained Release Agent Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Pharma Sustained Release Agent Sales in Volume by Country (2018-2023) & (Kiloton)
Table 36. Americas Pharma Sustained Release Agent Sales in Volume by Country (2024-2034) & (Kiloton)
Table 37. EMEA Pharma Sustained Release Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Pharma Sustained Release Agent Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Pharma Sustained Release Agent Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Pharma Sustained Release Agent Sales in Volume by Country (2018-2023) & (Kiloton)
Table 41. EMEA Pharma Sustained Release Agent Sales in Volume by Country (2024-2034) & (Kiloton)
Table 42. APAC Pharma Sustained Release Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Pharma Sustained Release Agent Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Pharma Sustained Release Agent Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Pharma Sustained Release Agent Sales in Volume by Country (2018-2023) & (Kiloton)
Table 46. APAC Pharma Sustained Release Agent Sales in Volume by Country (2024-2034) & (Kiloton)
Table 47. Teva Pharmaceutical Industries Company Information
Table 48. Teva Pharmaceutical Industries Description and Business Overview
Table 49. Teva Pharmaceutical Industries Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 50. Teva Pharmaceutical Industries Pharma Sustained Release Agent Product
Table 51. Teva Pharmaceutical Industries Recent Development
Table 52. Mylan N.V. Company Information
Table 53. Mylan N.V. Description and Business Overview
Table 54. Mylan N.V. Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 55. Mylan N.V. Pharma Sustained Release Agent Product
Table 56. Mylan N.V. Recent Development
Table 57. Valeant Pharmaceuticals International Company Information
Table 58. Valeant Pharmaceuticals International Description and Business Overview
Table 59. Valeant Pharmaceuticals International Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 60. Valeant Pharmaceuticals International Pharma Sustained Release Agent Product
Table 61. Valeant Pharmaceuticals International Recent Development
Table 62. Pfizer Company Information
Table 63. Pfizer Description and Business Overview
Table 64. Pfizer Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 65. Pfizer Pharma Sustained Release Agent Product
Table 66. Pfizer Recent Development
Table 67. Sun Pharmaceutical Industries Company Information
Table 68. Sun Pharmaceutical Industries Description and Business Overview
Table 69. Sun Pharmaceutical Industries Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 70. Sun Pharmaceutical Industries Pharma Sustained Release Agent Product
Table 71. Sun Pharmaceutical Industries Recent Development
Table 72. Novartis AG Company Information
Table 73. Novartis AG Description and Business Overview
Table 74. Novartis AG Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 75. Novartis AG Pharma Sustained Release Agent Product
Table 76. Novartis AG Recent Development
Table 77. AstraZeneca Company Information
Table 78. AstraZeneca Description and Business Overview
Table 79. AstraZeneca Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 80. AstraZeneca Pharma Sustained Release Agent Product
Table 81. AstraZeneca Recent Development
Table 82. GlaxoSmithKline Company Information
Table 83. GlaxoSmithKline Description and Business Overview
Table 84. GlaxoSmithKline Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 85. GlaxoSmithKline Pharma Sustained Release Agent Product
Table 86. GlaxoSmithKline Recent Development
Table 87. Allergan Company Information
Table 88. Allergan Description and Business Overview
Table 89. Allergan Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 90. Allergan Pharma Sustained Release Agent Product
Table 91. Allergan Recent Development
Table 92. Janssen Pharmaceuticals Company Information
Table 93. Janssen Pharmaceuticals Description and Business Overview
Table 94. Janssen Pharmaceuticals Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 95. Janssen Pharmaceuticals Pharma Sustained Release Agent Product
Table 96. Janssen Pharmaceuticals Recent Development
Table 97. Mayne Pharma Group Company Information
Table 98. Mayne Pharma Group Description and Business Overview
Table 99. Mayne Pharma Group Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 100. Mayne Pharma Group Pharma Sustained Release Agent Product
Table 101. Mayne Pharma Group Recent Development
Table 102. BASF Company Information
Table 103. BASF Description and Business Overview
Table 104. BASF Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 105. BASF Pharma Sustained Release Agent Product
Table 106. BASF Recent Development
Table 107. International Flavors & Fragrances Company Information
Table 108. International Flavors & Fragrances Description and Business Overview
Table 109. International Flavors & Fragrances Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 110. International Flavors & Fragrances Pharma Sustained Release Agent Product
Table 111. International Flavors & Fragrances Recent Development
Table 112. Ashland Global Company Information
Table 113. Ashland Global Description and Business Overview
Table 114. Ashland Global Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 115. Ashland Global Pharma Sustained Release Agent Product
Table 116. Ashland Global Recent Development
Table 117. Evonik Industries Company Information
Table 118. Evonik Industries Description and Business Overview
Table 119. Evonik Industries Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 120. Evonik Industries Pharma Sustained Release Agent Product
Table 121. Evonik Industries Recent Development
Table 122. Croda International Company Information
Table 123. Croda International Description and Business Overview
Table 124. Croda International Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 125. Croda International Pharma Sustained Release Agent Product
Table 126. Croda International Recent Development
Table 127. Gattefosse Company Information
Table 128. Gattefosse Description and Business Overview
Table 129. Gattefosse Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 130. Gattefosse Pharma Sustained Release Agent Product
Table 131. Gattefosse Recent Development
Table 132. Merck KGaA Company Information
Table 133. Merck KGaA Description and Business Overview
Table 134. Merck KGaA Pharma Sustained Release Agent Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 135. Merck KGaA Pharma Sustained Release Agent Product
Table 136. Merck KGaA Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Pharma Sustained Release Agent Customers List
Table 140. Pharma Sustained Release Agent Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Sustained Release Agent Product Picture
Figure 2. Global Pharma Sustained Release Agent Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Pharma Sustained Release Agent Market Size 2018-2034 (US$ Million)
Figure 4. Global Pharma Sustained Release Agent Sales 2018-2034 (Kiloton)
Figure 5. India Pharma Sustained Release Agent Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Pharma Sustained Release Agent Market Size 2018-2034 (US$ Million)
Figure 7. India Pharma Sustained Release Agent Sales 2018-2034 (Kiloton)
Figure 8. India Pharma Sustained Release Agent Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Pharma Sustained Release Agent Market Share in Global, in Volume (Kiloton) 2018-2034
Figure 10. Pharma Sustained Release Agent Report Years Considered
Figure 11. Product Picture of Gelatin
Figure 12. Product Picture of Polymers
Figure 13. Product Picture of Minerals
Figure 14. Product Picture of Sugars
Figure 15. Product Picture of Chitosan
Figure 16. Global Pharma Sustained Release Agent Market Share by Type in 2024 & 2034
Figure 17. Global Pharma Sustained Release Agent Sales in Value by Type (2018-2034) & (US$ Million)
Figure 18. Global Pharma Sustained Release Agent Sales Market Share in Value by Type (2018-2034)
Figure 19. Global Pharma Sustained Release Agent Sales by Type (2018-2034) & (Kiloton)
Figure 20. Global Pharma Sustained Release Agent Sales Market Share in Volume by Type (2018-2034)
Figure 21. Global Pharma Sustained Release Agent Price by Type (2018-2034) & (US$/Ton)
Figure 22. India Pharma Sustained Release Agent Market Share by Type in 2024 & 2034
Figure 23. India Pharma Sustained Release Agent Sales in Value by Type (2018-2034) & (US$ Million)
Figure 24. India Pharma Sustained Release Agent Sales Market Share in Value by Type (2018-2034)
Figure 25. India Pharma Sustained Release Agent Sales by Type (2018-2034) & (Kiloton)
Figure 26. India Pharma Sustained Release Agent Sales Market Share in Volume by Type (2018-2034)
Figure 27. India Pharma Sustained Release Agent Price by Type (2018-2034) & (US$/Ton)
Figure 28. Product Picture of Pharmaceutical
Figure 29. Product Picture of Health Care
Figure 30. Product Picture of Others
Figure 31. Global Pharma Sustained Release Agent Market Share by Application in 2024 & 2034
Figure 32. Global Pharma Sustained Release Agent Sales in Value by Application (2018-2034) & (US$ Million)
Figure 33. Global Pharma Sustained Release Agent Sales Market Share in Value by Application (2018-2034)
Figure 34. Global Pharma Sustained Release Agent Sales by Application (2018-2034) & (Kiloton)
Figure 35. Global Pharma Sustained Release Agent Sales Market Share in Volume by Application (2018-2034)
Figure 36. Global Pharma Sustained Release Agent Price by Application (2018-2034) & (US$/Ton)
Figure 37. India Pharma Sustained Release Agent Market Share by Application in 2024 & 2034
Figure 38. India Pharma Sustained Release Agent Sales in Value by Application (2018-2034) & (US$ Million)
Figure 39. India Pharma Sustained Release Agent Sales Market Share in Value by Application (2018-2034)
Figure 40. India Pharma Sustained Release Agent Sales by Application (2018-2034) & (Kiloton)
Figure 41. India Pharma Sustained Release Agent Sales Market Share in Volume by Application (2018-2034)
Figure 42. India Pharma Sustained Release Agent Price by Application (2018-2034) & (US$/Ton)
Figure 43. Americas Pharma Sustained Release Agent Sales in Volume Growth Rate 2018-2034 (Kiloton)
Figure 44. Americas Pharma Sustained Release Agent Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 45. Americas Pharma Sustained Release Agent Sales by Type (2018-2034) & (Kiloton)
Figure 46. Americas Pharma Sustained Release Agent Sales Market Share in Volume by Type (2018-2034)
Figure 47. Americas Pharma Sustained Release Agent Sales by Application (2018-2034) & (Kiloton)
Figure 48. Americas Pharma Sustained Release Agent Sales Market Share in Volume by Application (2018-2034)
Figure 49. United States Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Canada Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Mexico Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. EMEA Pharma Sustained Release Agent Sales in Volume Growth Rate 2018-2034 (Kiloton)
Figure 54. EMEA Pharma Sustained Release Agent Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 55. EMEA Pharma Sustained Release Agent Sales by Type (2018-2034) & (Kiloton)
Figure 56. EMEA Pharma Sustained Release Agent Sales Market Share in Volume by Type (2018-2034)
Figure 57. EMEA Pharma Sustained Release Agent Sales by Application (2018-2034) & (Kiloton)
Figure 58. EMEA Pharma Sustained Release Agent Sales Market Share in Volume by Application (2018-2034)
Figure 59. Europe Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Middle East Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Africa Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. China Pharma Sustained Release Agent Sales in Volume Growth Rate 2018-2034 (Kiloton)
Figure 63. China Pharma Sustained Release Agent Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 64. China Pharma Sustained Release Agent Sales by Type (2018-2034) & (Kiloton)
Figure 65. China Pharma Sustained Release Agent Sales Market Share in Volume by Type (2018-2034)
Figure 66. China Pharma Sustained Release Agent Sales by Application (2018-2034) & (Kiloton)
Figure 67. China Pharma Sustained Release Agent Sales Market Share in Volume by Application (2018-2034)
Figure 68. APAC Pharma Sustained Release Agent Sales in Volume Growth Rate 2018-2034 (Kiloton)
Figure 69. APAC Pharma Sustained Release Agent Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 70. APAC Pharma Sustained Release Agent Sales by Type (2018-2034) & (Kiloton)
Figure 71. APAC Pharma Sustained Release Agent Sales Market Share in Volume by Type (2018-2034)
Figure 72. APAC Pharma Sustained Release Agent Sales by Application (2018-2034) & (Kiloton)
Figure 73. APAC Pharma Sustained Release Agent Sales Market Share in Volume by Application (2018-2034)
Figure 74. Japan Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. South Korea Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. China Taiwan Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. India Pharma Sustained Release Agent Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. Pharma Sustained Release Agent Value Chain
Figure 80. Pharma Sustained Release Agent Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed